| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |